|
Launch of new products “Twofull-A” and “Karumen Plus”
2013.03.08
|
|---|
|
Launch of New Products Twofull-A and Karumen Plus
Recently, Daehan New Pharm launched two new pellet-type products effective in cattle management: Twofull-A, which improves weight gain and suppresses estrus, and Karumen Plus, which enhances feed efficiency and increases milk production.
Twofull-A, an approved veterinary drug, uses melengestrol, a beef growth-promoting hormone approved by the U.S. FDA. It stimulates protein and muscle development in heifers, promoting growth and finishing while improving feed efficiency. When administered to beef cattle, it enables earlier shipment (by 10–30 days), improves carcass grades for higher profitability, and suppresses estrus in females to prevent unwanted breeding, thereby enhancing productivity.
Karumen Plus, also an approved veterinary drug, contains monensin as its main ingredient. It boosts growth and weight gain in beef cattle, prevents coccidiosis, and improves milk yield in dairy cows. Monensin alters rumen microbiota to increase volatile fatty acids that efficiently provide energy, while suppressing harmful microorganisms that produce lactic acid and methane. It also helps prevent acidosis, bloat, ketosis, and reduces the incidence of liver abscesses.
Both Twofull-A and Karumen Plus are produced in pellet form. They are the first patented formulations of their kind: melengestrol pellet (Patent Application No. 10-2013-00008604) and monensin pellet additive (Patent Application No. 10-2013-00008605). Compared to powders, pellets are easier to administer, offer better palatability, and allow uniform individual dosing, increasing effectiveness. Additionally, the newly patented low-temperature pellet manufacturing process prevents potency loss during molding, maintaining the ingredients’ efficacy.
By launching Twofull-A and Karumen Plus, both of which significantly enhance feed efficiency and weight gain in beef cattle, the company aims to support livestock farmers facing rising feed costs and production expenses due to global grain price increases.
In addition, the company has also launched Lactorin Acid, an antibiotic alternative derived from fermented fish sauce, which has received positive feedback from farmers.
|


Home